Hajar Alemohammad

509 total citations
12 papers, 365 citations indexed

About

Hajar Alemohammad is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hajar Alemohammad has authored 12 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Hajar Alemohammad's work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and Epigenetics and DNA Methylation (3 papers). Hajar Alemohammad is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and Epigenetics and DNA Methylation (3 papers). Hajar Alemohammad collaborates with scholars based in Iran, Italy and Australia. Hajar Alemohammad's co-authors include Basira Najafzadeh, Amir Baghbanzadeh, Zahra Asadzadeh, Souzan Najafi, Behzad Baradaran, Behzad Baradaran, Farid Ghorbaninezhad, Nima Hemmat, Mahdi Abdoli Shadbad and Rouhollah Motafakkerazad and has published in prestigious journals such as Gene, Experimental Cell Research and Life Sciences.

In The Last Decade

Hajar Alemohammad

12 papers receiving 362 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hajar Alemohammad	194	127	90	86	40	12	365
Basira Najafzadeh	183 0.9×	119 0.9×	75 0.8×	81 0.9×	39 1.0×	11	342
Ying Kong	379 2.0×	114 0.9×	58 0.6×	77 0.9×	18 0.5×	27	497
Farid Ghorbaninezhad	126 0.6×	140 1.1×	157 1.7×	61 0.7×	11 0.3×	26	333
Pegah Johansson	213 1.1×	118 0.9×	47 0.5×	54 0.6×	14 0.3×	26	342
Tainá Gomes	227 1.2×	71 0.6×	276 3.1×	70 0.8×	18 0.5×	13	493
Robert Valentine	210 1.1×	188 1.5×	80 0.9×	122 1.4×	28 0.7×	4	441
Hung Sing Li	111 0.6×	88 0.7×	53 0.6×	55 0.6×	57 1.4×	13	293
Kelsey E. Huntington	129 0.7×	100 0.8×	91 1.0×	35 0.4×	30 0.8×	35	297
Mordehay Klepfish	155 0.8×	170 1.3×	199 2.2×	91 1.1×	15 0.4×	6	444
Zhenqing Feng	201 1.0×	179 1.4×	77 0.9×	48 0.6×	12 0.3×	30	408

Countries citing papers authored by Hajar Alemohammad

Since Specialization

Citations

This map shows the geographic impact of Hajar Alemohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajar Alemohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajar Alemohammad more than expected).

Fields of papers citing papers by Hajar Alemohammad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajar Alemohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajar Alemohammad. The network helps show where Hajar Alemohammad may publish in the future.

Co-authorship network of co-authors of Hajar Alemohammad

This figure shows the co-authorship network connecting the top 25 collaborators of Hajar Alemohammad. A scholar is included among the top collaborators of Hajar Alemohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajar Alemohammad. Hajar Alemohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Najafi, Souzan, Rouhollah Motafakkerazad, Mohammad Amini, et al.. (2023). Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells. Experimental Cell Research. 429(2). 113681–113681. 3 indexed citations

Ghorbaninezhad, Farid, Hajar Alemohammad, Basira Najafzadeh, et al.. (2023). Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?. Cancer Letters. 562. 216168–216168. 29 indexed citations

Najafzadeh, Basira, Rouhollah Motafakkerazad, Souzan Najafi, et al.. (2022). Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration. Pathology - Research and Practice. 233. 153869–153869. 4 indexed citations

Motafakkerazad, Rouhollah, Leili Aghebati‐Maleki, Souzan Najafi, et al.. (2022). Nanog, as a key cancer stem cell marker in tumor progression. Gene. 827. 146448–146448. 66 indexed citations

Alemohammad, Hajar, Rouhollah Motafakkerazad, Zahra Asadzadeh, et al.. (2022). siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin. Gene. 821. 146333–146333. 10 indexed citations

Ghorbaninezhad, Farid, Patrizia Leone, Hajar Alemohammad, et al.. (2022). Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review). International Journal of Molecular Medicine. 49(4). 38 indexed citations

Alemohammad, Hajar, Basira Najafzadeh, Zahra Asadzadeh, et al.. (2021). The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomedicine & Pharmacotherapy. 146. 112516–112516. 65 indexed citations

Baradaran, Ali, Zahra Asadzadeh, Nima Hemmat, et al.. (2021). The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy. Biomedicine & Pharmacotherapy. 146. 112588–112588. 23 indexed citations

Hemmat, Nima, Zahra Asadzadeh, Hajar Alemohammad, et al.. (2021). The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Archives of Virology. 166(3). 675–696. 63 indexed citations

10.

Alemohammad, Hajar, Zahra Asadzadeh, Nima Hemmat, et al.. (2020). Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction. Life Sciences. 260. 118337–118337. 16 indexed citations

11.

Hemmat, Nima, Zahra Asadzadeh, Hajar Alemohammad, et al.. (2020). The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?. 1 indexed citations

12.

Najafzadeh, Basira, Zahra Asadzadeh, Ahad Mokhtarzadeh, et al.. (2020). The oncogenic potential of NANOG: An important cancer induction mediator. Journal of Cellular Physiology. 236(4). 2443–2458. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact